肺炎喘嗽液治疗小儿急性呼吸道感染的临床及实验研究

作者	单位
彭兆麟	Peng Zhaolin, Peng Wenjuan, Chen Taohou, et al (Wuhan Children’s Hospital, Wuhan (430016
彭文娟	Peng Zhaolin, Peng Wenjuan, Chen Taohou, et al (Wuhan Children’s Hospital, Wuhan (430016
陈陶后	Peng Zhaolin, Peng Wenjuan, Chen Taohou, et al (Wuhan Children’s Hospital, Wuhan (430016
彭智聪	Peng Zhaolin, Peng Wenjuan, Chen Taohou, et al (Wuhan Children’s Hospital, Wuhan (430016

摘要点击次数: 1485

全文下载次数: 857

中文摘要:

观察肺炎喘嗽液治疗小儿急性呼吸道感染的疗效。方法：应用肺炎喘嗽液治疗小儿急性呼吸道感染的临床及实验研究。结果：临床结果显示肺炎喘嗽液对止咳、化痰、平喘和消除干、湿罗音、哮鸣音均较对照组为优（Ｐ＜０．０５）。动物实验结果显示肺炎喘嗽液对止咳、化痰、平喘均有显著作用（Ｐ＜０．０５～０．００１）。体外抑菌实验其原液对肺炎链球菌、肺炎克雷伯杆菌、流感杆菌和金黄色葡萄球菌都有抑制作用。病毒实验显示该制剂对甲型流感病毒与呼吸道合胞病毒有完全抑制作用。结论：肺炎喘嗽液治疗小儿急性呼吸道感染疗效肯定。

英文摘要:

To study the therapeutical mechanism of Feiyan Chuansou Oral Liquid (FCOL) in treating infantile acute respiratory trot infection. Mathods: Clinical and experimental studies with FCOL in treating infantile acute respiratory tract infection. Results: The clinical result showed that the antitussive, expectorant, anti- asthmatic effect and resolution of dry and moist rale and wheezing of FCOL were significantly better in treatment group than those in the control group (P<0. 05). Animal experimental results also showed that antitussive, expectorant, anti-asthmatic effect of FCOL were significantly better than those of the control group (P<0.05～0. 001). Bacteriostatic test in vitro showed that FCOL could inhibit streptococcus pneumoniae, klebsiella pneumoniae, influenza bacilli and staphylococcus aureus. Antivirologic test showed that FCOL could inhibit completely the innuenza A virus and respiratory syncytial virus. Conclusion: FCOL is an effective preparation in treating infantile acute respiratory infection.

关闭